CORONAVIRUS (COVID-19) RESOURCE CENTER Read More

HR 3

Title: Elijah E. Cummings Lower Drug Costs Now Act
Author: Rep. Frank Pallone (D-NJ)

Summary
Centers for Medicare & Medicaid Services (CMS) to negotiate prices for certain drugs (current law prohibits the CMS from doing so). Specifically, the CMS must negotiate maximum prices for (1) insulin products; and (2) at least 25 single source, brand-name drugs that do not have generic competition and that are among the 125 drugs that account for the greatest national spending or the 125 drugs that account for the greatest spending under the Medicare prescription drug benefit and Medicare Advantage (MA). The negotiated prices must be offered under Medicare and MA, and may also be offered under private health insurance unless the insurer opts out.</p> <p>The negotiated maximum price may not exceed (1) 120% of the average price in Australia, Canada, France, Germany, Japan, and the United ...

Status
Introduced in House 09/19/2019
Introduced in House 09/19/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 09/19/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 09/19/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 09/19/2019
Referred to the Subcommittee on Health. 09/20/2019
Subcommittee Hearings Held. 09/25/2019
Committee Consideration and Mark-up Session Held. 10/17/2019
Ordered to be Reported (Amended) by the Yeas and Nays: 27 - 21. 10/17/2019
Committee Consideration and Mark-up Session Held. 10/22/2019
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 24 - 17. 10/22/2019
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-324, Part I. 12/06/2019
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-324, Part I. 12/06/2019
Reported (Amended) by the Committee on Ways and Means. H. Rept. 116-324, Part II. 12/06/2019
Reported (Amended) by the Committee on Ways and Means. H. Rept. 116-324, Part II. 12/06/2019
House Committee on Education and Labor Granted an extension for further consideration ending not later than Dec. 9, 2019. 12/06/2019
Reported (Amended) by the Committee on Education and Labor. H. Rept. 116-324, Part III. 12/09/2019
Reported (Amended) by the Committee on Education and Labor. H. Rept. 116-324, Part III. 12/09/2019
Placed on the Union Calendar, Calendar No. 264. 12/09/2019
Rules Committee Resolution H. Res. 758 Reported to House. The rule provides for consideration of H.R. 3, under a structured rule, with 4 hours of general debate. The rule provides for consideration of H.R. 5038 under a closed rule, with 1 hour of general debate. The rule provides for consideration of the conference report to accompany S. 1790 with 1 hour of debate. 12/10/2019
Considered under the provisions of rule H. Res. 758. (consideration: CR H10096-10117) 12/11/2019
The rule provides for consideration of H.R. 3, under a structured rule, with 4 hours of general debate. The rule provides for consideration of H.R. 5038 under a closed rule, with 1 hour of general debate. The rule provides for consideration of the conference report to accompany S. 1790 with 1 hour of debate. 12/11/2019
House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 758 and Rule XVIII. 12/11/2019
The Speaker designated the Honorable Donald M. Payne, Jr. to act as Chairman of the Committee. 12/11/2019
GENERAL DEBATE - The Committee of the Whole proceeded with four hours of general debate on H.R. 3. 12/11/2019
Mr. Scott (VA) moved that the Committee rise. 12/11/2019
On motion that the Committee rise Agreed to by voice vote. 12/11/2019
Committee of the Whole House on the state of the Union rises leaving H.R. 3 as unfinished business. 12/11/2019
Considered as unfinished business. (consideration: CR H10129-10225; text: CR H10141-10167) 12/12/2019
The House resolved into Committee of the Whole House on the state of the Union for further consideration. 12/12/2019
GENERAL DEBATE - The Committee of the Whole proceeded with one hour of further debate on H.R. 3. 12/12/2019
DEBATE - Pursuant to the provisions of H.Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Walden amendment No. 1. 12/12/2019
POSTPONED PROCEEDINGS - At the conclusion of debate on the Walden amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the noes had prevailed. Mr. Walden demanded a recorded vote and the Chair postponed further proceedings until a time to be announced. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Tonko amendment No. 2. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Peters amendment No. 3. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Kennedy amendment No. 4. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the O'Halleran amendment No. 5. 12/12/2019
POSTPONED PROCEEDINGS - At the conclusion of debate on the O'Halleran amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. O'Halleran demanded a recorded vote and the Chair postponed further proceedings until a time to be announced. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Kennedy amendment No. 6. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Gottheimer amendment No. 7. 12/12/2019
POSTPONED PROCEEDINGS - At the conclusion of debate on the Gottheimer amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. Gottheimer demanded a recorded vote and the Chair postponed further proceedings until a time to be announced. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Axne amendment No. 8. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Finkenauer amendment No. 9. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Luria amendment No. 10. 12/12/2019
POSTPONED PROCEEDINGS - At the conclusion of debate on the Luria amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. Walden demanded a recorded vote and the Chair postponed further proceedings until a time to be announced. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Cunningham amendment No. 11. 12/12/2019
POSTPONED PROCEEDINGS - At the conclusion of debate on the Cunningham amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. Roe (TN) demanded a recorded vote and the Chair postponed further proceedings until a time to be announced. 12/12/2019
DEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Houlahan amendment No. 12. 12/12/2019
UNFINISHED BUSINESS - The Chair announced that the unfinished business was on adoption of amendments, which were debated earlier and on which further proceedings had been postponed. 12/12/2019
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 3. 12/12/2019
The previous question was ordered pursuant to the rule. 12/12/2019
The House adopted the amendments en gross as agreed to by the Committee of the Whole House on the state of the Union. 12/12/2019
Mr. Upton moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H10223) 12/12/2019
DEBATE - The House proceeded with 10 minutes of debate on the Upton motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to change the effective date of the Act until the Secretary of Health and Human Services certifies that the implementation of the provisions in the bill are not projected to result in fewer new drug applications with respect to unmet medical needs and life saving cures. 12/12/2019
The previous question on the motion to recommit with instructions was ordered without objection. 12/12/2019
On motion to recommit with instructions Failed by the Yeas and Nays: 196 - 226 (Roll no. 681). 12/12/2019
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 230 - 192 (Roll no. 682). 12/12/2019
On passage Passed by the Yeas and Nays: 230 - 192 (Roll no. 682). 12/12/2019
Motion to reconsider laid on the table Agreed to without objection. 12/12/2019
Received in the Senate. 12/16/2019

Bill Text
12/09/2019 - HR 3 (Reported+in+House)

Add To Favorites

Author Details


    Rep. Frank Pallone (D-NJ)
    U.S. Representative

    Visit their Website

    Contact Tips

    Capital Address:
    2107 Rayburn House Office Building

    Washington, DC 20515-3006
    Phone: (202) 225-4671

    District Address:
    504 Broadway

    Long Branch, NJ 07740
    Phone: (732) 571-1140
    Fax: (732) 870-3890